View this email in your browser ([link removed])
[link removed]
[link removed]

Your source for the latest news in drug policy. Visit our website ([link removed]) for more news.

A study ([link removed]) published in Mayo Clinic Proceedings: Innovations, Quality & Outcomes found that many state-level qualifying conditions for medical marijuana lack supporting evidence, as contrasted by the conclusions of a 2017 report about marijuana ([link removed]) from National Academies of Sciences, Engineering, and Medicine (NASEM).


The report from the NASEM assessed the potential therapeutic effects of marijuana for more than 20 medical conditions. At the same time, states that have legalized medical marijuana have determined their own lists of qualifying conditions. This study sought to review the degree of evidence from the NASEM report for the qualifying conditions that have been adopted by states.


Among the 20 most common qualifying conditions, the study found that only one was classified by the NASEM report as having substantial evidence for effectiveness. The list of qualifying conditions that had limited supporting evidence included glaucoma, epilepsy, and Alzheimer’s.


The study concluded, “these findings highlight a disparity between state-level [medical marijuana] recommendations and the evidence to support them.” Rather than states following the science, the authors noted, “our results support the notion that states use other information to guide [qualifying conditions] selection, including voter initiatives and public opinion.”


The Food and Drug Administration (FDA) has not approved marijuana ([link removed]) for the treatment of any disease or condition, meaning so-called “medical marijuana” is not an actual medicine.
Received this email from a friend? Sign up here! ([link removed])
[link removed]

[link removed]
[link removed]
[link removed]
[link removed]
[link removed]

Smart Approaches to Marijuana (SAM) ([link removed]) is an alliance of organizations and individuals dedicated to a health-first approach to marijuana policy. We are professionals working in mental health and public health. We are bipartisan. We are medical doctors, lawmakers, treatment providers, preventionists, teachers, law enforcement officers and others who seek a middle road between incarceration and legalization. Our commonsense, third-way approach to marijuana policy is based on reputable science and sound principles of public health and safety.

Copyright (C) 2025 Smart Approaches to Marijuana (SAM). All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
Smart Approaches to Marijuana (SAM)
107 S West St. Ste. 757
Alexandria, VA 22314
USA
Want to change how you receive these emails?
You can update your preferences ([link removed]) or unsubscribe ([link removed])

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Smart Approaches to Marijuana (SAM) . 107 S West St. Ste. 757 . Alexandria, VA 22314 . USA